Neumora Therapeutics, Inc. ($NMRA)
Filing Information
| Accession Number | 0001610717-26-000362 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 19, 2026 |
| Document | View SEC Filing |
Transactions
29
Total Shares
765,279
Total Value
$607,176.27
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating and Development Officer | Common Stock | โ | Aug 17, 2026 | Exercise/Conversion | 40,890 | $0.72 | $29,440.80 | 123,660 | Direct | โ | View Details | |
Chief Operating and Development Officer | Common Stock | โ | Aug 17, 2026 | Exercise/Conversion | 15,355 | $0.72 | $11,055.60 | 139,015 | Direct | โ | View Details | |
Chief Operating and Development Officer | Common Stock | โ | Aug 17, 2026 | Exercise/Conversion | 1,424 | $0.72 | $1,025.28 | 140,439 | Direct | โ | View Details | |
Chief Operating and Development Officer | Common Stock | โ | Aug 17, 2026 | Exercise/Conversion | 1 | $0.72 | $0.72 | 140,440 | Direct | โ | View Details | |
Chief Operating and Development Officer | Common Stock | โ | Aug 17, 2026 | Sale | 57,670 | $1.51 | $86,822.18 | 82,770 | Direct | โ | View Details | |
Chief Operating and Development Officer | Common Stock | โ | Aug 17, 2026 | Sale | 34,020 | $1.49 | $50,529.91 | 48,750 | Direct | โ | View Details | |
Chief Operating and Development Officer | Common Stock | โ | Aug 17, 2026 | Exercise/Conversion | 25,279 | $0.72 | $18,200.88 | 25,279 | Indirect | See footnote | View Details | |
Chief Operating and Development Officer | Common Stock | โ | Aug 17, 2026 | Exercise/Conversion | 29,737 | $0.72 | $21,410.64 | 55,016 | Indirect | See footnote | View Details | |
Chief Operating and Development Officer | Common Stock | โ | Aug 17, 2026 | Sale | 55,016 | $1.50 | $82,782.58 | 0 | Indirect | See footnote | View Details | |
Chief Operating and Development Officer | Common Stock | โ | Aug 18, 2026 | Exercise/Conversion | 34,162 | $0.72 | $24,596.64 | 82,912 | Direct | โ | View Details | |
Chief Operating and Development Officer | Common Stock | โ | Aug 18, 2026 | Sale | 34,162 | $1.58 | $54,136.52 | 48,750 | Direct | โ | View Details | |
Chief Operating and Development Officer | Common Stock | โ | Aug 18, 2026 | Exercise/Conversion | 34,987 | $0.72 | $25,190.64 | 34,987 | Indirect | See footnote | View Details | |
Chief Operating and Development Officer | Common Stock | โ | Aug 18, 2026 | Sale | 34,987 | $1.59 | $55,485.88 | 0 | Indirect | See footnote | View Details | |
Chief Operating and Development Officer | Common Stock | โ | Aug 19, 2026 | Exercise/Conversion | 13,268 | $0.72 | $9,552.96 | 62,018 | Direct | โ | View Details | |
Chief Operating and Development Officer | Common Stock | โ | Aug 19, 2026 | Exercise/Conversion | 17,732 | $0.72 | $12,767.04 | 79,750 | Direct | โ | View Details | |
Chief Operating and Development Officer | Common Stock | โ | Aug 19, 2026 | Sale | 31,000 | $1.65 | $51,029.10 | 48,750 | Direct | โ | View Details | |
Chief Operating and Development Officer | Common Stock | โ | Aug 19, 2026 | Exercise/Conversion | 30,918 | $0.72 | $22,260.96 | 30,918 | Indirect | See footnote | View Details | |
Chief Operating and Development Officer | Common Stock | โ | Aug 19, 2026 | Sale | 30,918 | $1.65 | $50,887.94 | 0 | Indirect | See footnote | View Details | |
Chief Operating and Development Officer | Stock Option (Right to Buy) | Derivative | Aug 17, 2026 | Exercise/Conversion | 40,890 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Chief Operating and Development Officer | Stock Option (Right to Buy) | Derivative | Aug 17, 2026 | Exercise/Conversion | 15,355 | $0.00 | $0.00 | 192,546 | Direct | โ | View Details | |
Chief Operating and Development Officer | Stock Option (Right to Buy) | Derivative | Aug 17, 2026 | Exercise/Conversion | 1,424 | $0.00 | $0.00 | 70,797 | Direct | โ | View Details | |
Chief Operating and Development Officer | Stock Option (Right to Buy) | Derivative | Aug 17, 2026 | Exercise/Conversion | 1 | $0.00 | $0.00 | 999,999 | Direct | โ | View Details | |
Chief Operating and Development Officer | Stock Option (Right to Buy) | Derivative | Aug 17, 2026 | Exercise/Conversion | 25,279 | $0.00 | $0.00 | 110,931 | Indirect | See footnote | View Details | |
Chief Operating and Development Officer | Stock Option (Right to Buy) | Derivative | Aug 17, 2026 | Exercise/Conversion | 29,737 | $0.00 | $0.00 | 0 | Indirect | See footnote | View Details | |
Chief Operating and Development Officer | Stock Option (Right to Buy) | Derivative | Aug 18, 2026 | Exercise/Conversion | 34,162 | $0.00 | $0.00 | 36,635 | Direct | โ | View Details | |
Chief Operating and Development Officer | Stock Option (Right to Buy) | Derivative | Aug 18, 2026 | Exercise/Conversion | 34,987 | $0.00 | $0.00 | 75,944 | Indirect | See footnote | View Details | |
Chief Operating and Development Officer | Stock Option (Right to Buy) | Derivative | Aug 19, 2026 | Exercise/Conversion | 13,268 | $0.00 | $0.00 | 23,367 | Direct | โ | View Details | |
Chief Operating and Development Officer | Stock Option (Right to Buy) | Derivative | Aug 19, 2026 | Exercise/Conversion | 17,732 | $0.00 | $0.00 | 177,268 | Direct | โ | View Details | |
Chief Operating and Development Officer | Stock Option (Right to Buy) | Derivative | Aug 19, 2026 | Exercise/Conversion | 30,918 | $0.00 | $0.00 | 45,026 | Indirect | See footnote | View Details |